Institute For Prostate Cancer

Founded in 2011 and headquartered in Maharashtra, India.

2011 | Pune, Maharashtra (India) | Active
Last Updated:

Institute For Prostate Cancer Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth -100.00%
  • Profit Growth 56.78%
  • Ebitda -4.13%
  • Net Worth -1.57%
  • Total Assets -2.39%

About Institute For Prostate Cancer

Institute For Prostate Cancer (IFPC) is a Private Not For Profit Company incorporated in India on 22 November 2011 and has a history of 13 years and three months. Its registered office is in Pune, Maharashtra, India.

The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Aarti Upadhye and Dattatraya Joglekar serve as directors at the Company.

Company Details

  • Location

    Pune, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U85100PN2011NPL141427

  • Company No.

    141427

  • Company Classification

    Private Not For Profit Company

  • Incorporation Date

    22 Nov 2011

  • Date of AGM

    02 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Pune

Industry

Healthcare

Who are the key members and board of directors at Institute For Prostate Cancer?

Board Members (2)

NameDesignationAppointment DateStatus
Dattatraya Joglekar Country flag representing In Additional Director 01-Jan-2021Current
Aarti Upadhye Country flag representing In Additional Director 01-Jan-2021Current

Financial Performance of Institute For Prostate Cancer.

Institute For Prostate Cancer, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial improvement in profitability, with a 56.78% increase in profit. The company's net worth dipped by a decrease of 1.57%.

Institute For Prostate Cancer revenue growth over time
Institute For Prostate Cancer profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-100.00%
Revenue from Operations
-100.00%
Total Assets
-2.39%
Profit or Loss
56.78%
Net Worth
-1.57%
EBITDA
-4.13%

What is the Ownership and Shareholding Structure of Institute For Prostate Cancer?

In 2023, Institute For Prostate Cancer had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Institute For Prostate Cancer?

Unlock and access historical data on people associated with Institute For Prostate Cancer, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Institute For Prostate Cancer

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Institute For Prostate Cancer, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Institute For Prostate Cancer's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Institute For Prostate Cancer

Recent activity within the organization

  • Annual General Meeting

    Institute For Prostate Cancer last Annual general meeting of members was held on 02 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Institute For Prostate Cancer has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.

  • Director Appointment

    Aarti Mahendra Upadhye was appointed as a Additional Director was appointed as a Additional Director on 01 Jan 2021 & has been associated with this company since 4 years 2 months .

  • Director Appointment

    Dattatraya Chintaman Joglekar was appointed as a Additional Director was appointed as a Additional Director on 01 Jan 2021 & has been associated with this company since 4 years 2 months .

  • Company Incorporation

    Institute For Prostate Cancer was registered on 22 Nov 2011 with Roc Pune & aged 13 years 3 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Institute For Prostate Cancer?

    Institute For Prostate Cancer was incorporated on 22 Nov 2011.

  • What is authorized share capital and paid-up capital of Institute For Prostate Cancer?

    The authorized share capital of Institute For Prostate Cancer is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Institute For Prostate Cancer?

    Currently 2 directors are associated with Institute For Prostate Cancer.

    • Aarti Mahendra Upadhye
    • Dattatraya Chintaman Joglekar

  • What is the registered address of Institute For Prostate Cancer?

    As per Ministry of Corporate Affairs (Mca), the registered address of Institute For Prostate Cancer is Cantonment Mundhwa India, Pune, Maharashtra, 411036.

  • What is the corporate identification number (CIN) and company number of Institute For Prostate Cancer?

    The corporate identification number (CIN) of Institute For Prostate Cancer is U85100PN2011NPL141427 and the company number is 141427 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Institute For Prostate Cancer?

    According to the financial reports for the fiscal year 2023, the revenue trend for Institute For Prostate Cancer has fallen by -100.00%.

  • What change has been observed in the net worth of Institute For Prostate Cancer, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Institute For Prostate Cancer has experienced an downturn of -1.57%.

  • When was the last Balance Sheet of Institute For Prostate Cancer filed with the ROC?

    The most recent Balance Sheet for Institute For Prostate Cancer was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Oncology Clinics & Cancer Treatment